Embraer delivered three defence aircraft during the third quarter alone. One C-390 and two A-29s accompanied improved production levelling as the manufacturer manages a growing international military aircraft workload.
Northrop Grumman has launched its US-built FORTITUDE gallium nitride chip. The device consolidates radio-frequency functions for radar, electronic warfare, satellite, GPS, and communications applications while reducing component count, weight, and power demand.
BAE Systems will supply 40 EPAWSS sets for F-15EX production. The $146.7 million award covers Lots Seven and Eight and sustains electronic warfare hardware manufacture through August 2030.
BAE Systems will build 32 ACV-R recovery vehicles in production. The $230.1 million award takes the fourth Amphibious Combat Vehicle variant into series manufacture through November 2028.
Raytheon has received another major SPY-6 hardware production modification award. The $511.5 million action extends radar manufacture and spares work through November 2031 across multiple US facilities.
Raytheon has secured a $24.4 billion SM-6 production contract award. The seven-year framework supports annual output above 500 missiles alongside factory automation, supplier expansion, and workforce investment.
Norway has completed its first live ESSM Block 2 firing. The campaign tested missile performance, upgraded Aegis software, communications, and active guidance before final fleet integration.
Rheinmetall and Argotec have launched their first defence surveillance satellite. The mission starts in-orbit validation of a scalable constellation concept backed by automated satellite manufacturing in Turin.
Ireland has ordered five Thales radars for military air surveillance. Production ramp-up will support first deliveries in 2027 as Dublin builds an independent recognised air picture.
Diehl Defence will build naval IRIS-T prototypes for Germany’s frigates. The contract moves the system beyond demonstration into prototype manufacture, integration, and comprehensive firing trials.